- PTAB Axes 2 Uniloc Patents, Trims Another In Tech Giant Row – The Patent Trial and Appeal Board handed down three decisions invalidating Uniloc patents under the theory that the patent claims were obvious.
- U.S. Supreme Court rebuffs Merck appeal in hepatitis C patent fight with Gilead – The Supreme Court declined to revive a $2.54 billion jury verdict for Merck after the Federal Circuit found that Merck’s patent claims concerning a family of compounds used to treat hepatitis C were overly broad.
- Fed. Circ. Won’t Undo PTAB Rulings On Motorola Patents – On Tuesday, in a trio of unanimous opinions, the Federal Circuit affirmed the Patent Trial and Appeal Board’s decisions that upheld Motorola patents.
Recent News on the Federal Circuit
